SETTLEMENT AGREEMENTSettlement Agreement • February 9th, 2018 • Aviragen Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledFebruary 9th, 2018 Company Industry JurisdictionThis Settlement Agreement (the “Agreement”), dated this 9th day of February, 2018 (the “Effective Date”), is by and among Digirad Corporation (“Digirad”) and East Hill Management Company, LLC (“East Hill” and together with Digirad, the “CAS Group”), Aviragen Therapeutics, Inc. (“Aviragen”) and Vaxart, Inc. (“Vaxart”).